Showing results (281-290 of 632) with videos related to
Sort By:
Pageof 64
Human Vaccines|October 13, 2011
Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in ArgentinaDiego Fridman, Andrea Monti, Marie-Claude Bonnet, et al.Human Vaccines|September 30, 2011
The stem cell patent landscape as relevant to cancer vaccinesShyh-Jen WangHuman Vaccines|September 30, 2011
Two doses of pandemic influenza A(H1N1) vaccine: tolerability in healthy young children in the NetherlandsTessa M van't Klooster, Jeanet M Kemmeren, Hester E de Melker, et al.Human Vaccines|August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adultsDaniel M Musher, Susan B Manoff, Richard D McFetridge, et al.Human Vaccines|August 24, 2011
Rubella seroprevalence among healthy individuals in Izmir, TurkeyZafer Kurugöl, Levent Midyat, Ebru Türkoğlu, et al.Human Vaccines|July 28, 2011
New generation typhoid vaccines: an effective preventive strategy to control typhoid fever in developing countriesRamesh Verma, Mohan Bairwa, Suraj Chawla, et al.Human Vaccines|July 26, 2011
Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutantsPeter van der Ley, Germie van den DobbelsteenHuman Vaccines|July 26, 2011
Hospitalization in Spain associated with malignant neoplasias of the vulva and vagina (1997-2008)Ruth Gil-Prieto, Javier Cortés Bordoy, José Manuel Ramón y Cajal, et al.Human Vaccines|August 26, 2011
Universal protein vaccines against Neisseria meningitidis serogroup B, Streptococcus pneumoniae and influenzaNicola Principi, Susanna EspositoHuman Vaccines|August 6, 2011
A recombinant mutant abrin A chain expressed in Escherichia coli can be used as an effective vaccine candidateYan-Hui Han, Shan Gao, Wen-Wen Xin, et al.Pageof 64